Despite advances in the understanding of psychopharmacology, up to 50% of patients with depression do not respond to first-line therapy. Learn how the impact of genetics on drug response may provide valuable insights and inform treatment decisions.
Monday, June 14th | 2021 | 12:00 pm EST, 9:00 am PST
Michele Casoli-Reardon, MD
Medical Director, MCPAP North
Associate Professor, Tufts Medical School
Massachusetts General Hospital for Children
North Shore Medical Center